Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,528.8
41.2 (1.66%)

 

  • STI Straits Times Index
    2,528.8
    41.2 (1.66%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,343.1
    15.0 (1.13%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,484.3
    131.9 (0.56%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,772.2
    7.3 (0.26%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    19,389.4
    724.8 (3.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,545.6
    206.7 (4.76%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,154.6M
  • Value: 1,885.1M
  • Rise: 274
  • Fall: 88
  • Unch: 450

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Genting Sing0.665+0.050
Singtel2.570+0.050
ThaiBev0.610+0.015
Mapletree Log Tr1.600+0.060
Rex Intl0.090+0.001
ESR-REIT0.320+0.010
YZJ Shipbldg SGD0.850+0.020
NetLink NBN Tr0.885-0.015
Ascendas Reit2.780+0.110
Medtecs Intl0.074+0.003

World Indices

World Indices
Name Last Change
Nasdaq 7,502.4 -295.2
HSI 23,484.3 +131.9
HSCEI 9,504.9 +57.4
Jakarta 4,545.6 +206.7
Nikkei 225 19,389.4 +724.8
SSE Comp 2,772.2 +7.3
Shanghai A 2,905.2 +7.7
Shanghai B 218.9 -0.2
KOSPI 1,717.7 +31.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 27 Mar 2020 17:07
Last (SGD): 0.074 Change: +0.003 High: 0.078 Remarks: -
Change (%): +4.23 Low: 0.072
Open 0.072 Yesterday's Close 0.071
Buy Price 0.074 Sell Price 0.075
Buy Volume ('000) 971.3 Sell Volume ('000) 752.6
Cumulative Volume ('000) 23,310.0 Cumulative Value 1,749,205
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00285 Trailing EPS (SGD) e 0.00285 NAV (SGD) b 0.1559
PE a 25.965 Trailing PE f 25.978 Price / NAV b 0.4747
Dividend (SGD) d - Cash In Hand (SGD) g 0.0075 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 9.867 Treasury Shares h -
Beta - 75 Daysi -0.569 R-Squared - 75 Days(%)i 0.12 Market Cap (M) 40.656
Beta - 500 Daysi -0.250 R-Squared - 500 Days (%)i 0.09 Enterprise Value (M) 93.356
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 102.8722 6-Month VWAP 0.108 Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Mar 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 40.656 25.965 25.978 0.4747 -
Industry Medical & Biotechnology SGX 938.169 19.105 19.897 1.2352 2.169
Medical Specialties SGX 923.309 47.194 45.935 5.1696 0.617
Index FTSE ST Catalist Index SGX 54.956 30.063 88.683 0.6603 2.909
Local Peer Top Glove SGX 5,354.701 43.935 42.644 6.0668 0.629
Local Peer Biolidics SGX 49.712 - - 6.4062 -
Local Peer Yunnan Energy SGX 43.794 - - 0.9014 -
Local Peer UG Healthcare SGX 34.316 13.693 16.871 0.8079 1.459
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 131,481.341 55.878 35.865 4.2293 1.549
Global Peer MEDTRONIC PLC NYSE 120,467.881 26.013 22.666 2.3253 2.315
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 109,414.474 37.241 29.603 3.6871 0.268
Global Peer DANAHER CORP NYSE 96,575.709 36.431 38.804 3.3684 0.465
Global Peer STRYKER CORP NYSE 59,680.114 16.797 28.651 4.6600 1.211
Global Peer BECTON DICKINSON & CO NYSE 58,730.648 - 78.622 2.7703 -
Global Peer INTUITIVE SURGICAL INC NASDAQ 57,255.368 50.763 41.510 6.9285 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 42,829.512 25.631 9.113 3.0864 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 41,081.647 56.884 39.241 9.9032 -
Global Peer BAXTER INTERNATIONAL INC NYSE 40,469.967 24.920 39.064 5.1345 0.925
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), RESMED INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), ZIMMER BIOMET HOLDINGS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), COOPER COS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), TELEFLEX INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WATERS CORP (NYSE), INSULET CORPORATION (NASDAQ), STERIS PLC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), BIO RAD LABORATORIES INC (NYSE), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), QIAGEN NV (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), HOLOGIC INC (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), PERKINELMER INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), ABIOMED INC (NASDAQ), NOVOCURE LTD (NASDAQ), COCHLEAR LTD (ASX), BRUKER CORPORATION (NASDAQ), PENUMBRA INC (NYSE), HARTA (Bursa), WEIGAO GROUP (HKEx), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), QUIDEL CORP (NASDAQ), MICROPORT (HKEx), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), TOPGLOV (Bursa), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), NEVRO CORP (NYSE), NUVASIVE INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), AK MEDICAL (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), LIVANOVA PLC (NASDAQ), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), STAAR SURGICAL CO (NASDAQ), CANTEL MEDICAL CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), BIOTELEMETRY INC (NASDAQ), ATRICURE INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), AVANOS MEDICAL INC (NYSE), ATRION CORP (NASDAQ), INOGEN INC (NASDAQ), VENUS MEDTECH-B (HKEx), LIFETECH SCI (HKEx), SHOCKWAVE MEDICAL INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), NANOSONICS LIMITED (ASX), CAREDX INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), CIRC (HKEx), AXONICS MODULATION TECHNLOGS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), NATUS MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INMODE LTD (NASDAQ), CERUS CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), CRYOLIFE INC (NYSE), SUPERMX (Bursa), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SURMODICS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), VERICEL CORP (NASDAQ), HESKA CORP (NASDAQ), YESTAR HEALTH (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), AXOGEN INC (NASDAQ), VAPOTHERM INC (NYSE), ANGIODYNAMICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ZYNEX INC (NASDAQ), SI BONE INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), VIEWRAY INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), QUOTIENT LTD (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), GENMARK DIAGNOSTICS INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), INVACARE CORP (NYSE), ALPHATEC HLDGS INC (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), KDL MEDICAL (HKEx), CORMEDIX INC (NYSE American), CYTOSORBENTS CORP (NASDAQ), PW MEDTECH (HKEx), GOLDEN MEDITECH (HKEx), BIOLIFE SOLUTIONS INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), CUTERA INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), DERMTECH INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), MODERN DENTAL (HKEx), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), PROFOUND MED CORP (NASDAQ), SOLITON INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), APYX MEDICAL CORPORATION (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SIENTRA INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), ELECTROMED INC (NYSE American), FONAR CORP (NASDAQ), TELA BIO INC (NASDAQ), YUNNAN ENERGY (HKEx), VOLITIONRX LIMITED (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), BIOMERICA INC (NASDAQ), PAVMED INC (NASDAQ), ONCOCYTE CORP (NYSE American), VINCENT MED (HKEx), RESAPP HEALTH LIMITED (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), NEPHROS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), SOMNOMED LIMITED (ASX), CLEARPOINT NEURO INC (NASDAQ), SDI LTD (ASX), DAXOR CORP (NYSE American), CONFORMIS INC (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), KELFRED (HKEx), APOLLO ENDOSURGERY INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), RETRACTABLE TECHNOLOGIES INC (NYSE American), CYCLOPHARM LIMITED (ASX), SENSUS HEALTHCARE INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), IMMUCELL CORP (NASDAQ), COMPUMEDICS (ASX), ZOSANO PHARMA CORP (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEURONETICS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), RESPIRI LTD (ASX), IRIDEX CORP (NASDAQ), CELSION CORPORATION (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), USCOM LTD (ASX), NANOVIBRONIX INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), LKL (Bursa), LIFE HEALTHCARE (HKEx), EMVISION MEDICAL DEVICES LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), MICRO-X LTD (ASX), NEUROTROPE INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), NEOVASC INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), AETHLON MEDICAL INC (NASDAQ), BIOLASE INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), LBT INNOVATIONS LTD (ASX), ENDOLOGIX INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DIMERIX LTD (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), CHECK-CAP LTD (NASDAQ), IMPEDIMED LIMITED (ASX), ELECTROCORE INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), CYANOTECH CORP (NASDAQ), CHF SOLUTIONS INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), DYNATRONICS CORP (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), DIGIRAD CORP (NASDAQ), AVINGER INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), OPTISCAN IMAGING (ASX), CARDIEX LTD (ASX), TITAN MEDICAL INC (NASDAQ), CANCER GENETICS INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), HUAKANG BIOMED (HKEx), AKERS BIOSCIENCES INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), STHAI (SET), MICRON SOLUTIONS INC (NYSE American), INSPIREMD INC (NYSE American), ADHERIUM LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), ANALYTICA (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), MEDIGARD LIMITED (ASX), NEUROMETRIX INC (NASDAQ), DORSAVI LTD (ASX), METALICITY LIMITED (ASX), SINTX TECHNOLOGIES INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.011
+17.46 %
10 Days --0.010
-11.90 %
20 Days --0.019
-20.43 %
Medium Term Return 3 Months -+0.037
+100.00 %
6 Months -+0.044
+146.67 %
1 Year -+0.046
+164.29 %
Long Term Return 2 Years -+0.029
+64.44 %
3 Years -+0.023
+45.10 %
5 Years -+0.022
+42.31 %
Annualised Return Annualised --
+7.31 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.022 - 0.210 Change From 1 Year Low +0.052 % Change From 1 Year Low (%) +236.36
Change From 1 Year High -0.136 % Change From 1 Year High (%) -64.76
2 Years Range 0.022 - 0.210 Change From 2 Years Low +0.052 % Change From 2 Years Low (%) +236.36
Change From 2 Years High -0.136 % Change From 2 Years High (%) -64.76
5 Years Range 0.022 - 0.210 Change From 5 Years Low +0.052 % Change From 5 Years Low (%) +236.36
Change From 5 Years High -0.136 % Change From 5 Years High (%) -64.76
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) -70.52 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
27 Mar 2020 0.072 0.078 0.072 0.074 23,310,000 0.0750
26 Mar 2020 0.073 0.073 0.067 0.071 7,606,900 0.0712
25 Mar 2020 0.074 0.075 0.071 0.073 14,293,600 0.0731
24 Mar 2020 0.068 0.075 0.065 0.071 14,997,700 0.0717
23 Mar 2020 0.068 0.069 0.063 0.068 19,771,800 0.0669
20 Mar 2020 0.062 0.066 0.060 0.063 12,062,600 0.0634
19 Mar 2020 0.064 0.066 0.055 0.060 16,190,800 0.0607
18 Mar 2020 0.073 0.078 0.062 0.064 18,055,100 0.0696
17 Mar 2020 0.077 0.079 0.071 0.073 9,073,300 0.0757
16 Mar 2020 0.083 0.087 0.078 0.079 12,023,500 0.0816
13 Mar 2020 0.093 0.093 0.081 0.084 44,065,400 0.0868
12 Mar 2020 0.086 0.094 0.081 0.092 100,406,800 0.0891
11 Mar 2020 0.064 0.083 0.064 0.078 103,371,200 0.0762
10 Mar 2020 0.057 0.068 0.057 0.063 18,400,100 0.0632
09 Mar 2020 0.072 0.072 0.056 0.056 15,319,500 0.0621
06 Mar 2020 0.082 0.082 0.074 0.076 16,072,100 0.0767
05 Mar 2020 0.083 0.087 0.081 0.082 19,152,500 0.0840
04 Mar 2020 0.087 0.089 0.081 0.082 13,114,700 0.0835
03 Mar 2020 0.094 0.095 0.087 0.087 18,765,900 0.0899
02 Mar 2020 0.093 0.097 0.092 0.093 19,883,300 0.0944
28 Feb 2020 0.092 0.098 0.091 0.093 23,733,100 0.0942
27 Feb 2020 0.094 0.096 0.088 0.092 16,167,900 0.0919
Summary
Current 2 Weeks
(16 Mar 2020 to 27 Mar 2020)
0.083 0.087 0.055 0.074 147,385,300 -
Previous 2 Weeks
(02 Mar 2020 to 13 Mar 2020)
0.093 0.097 0.055 0.084 368,551,500 -
4 Weeks from
(03 Feb 2020 to 28 Feb 2020)
0.122 0.140 0.055 0.093 1,809,672,500 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.